Clinical trial
Daridorexant for Alzheimer Disease Prevention
NCT07213349
Study timeline
Study start (actual)2025-10-14Date precision: day
Registry last updated2025-12-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Disease (AD)unresolved
Interventions
Daridorexant 50 mgDRUG · verified · RxNorm: daridorexant 50 MG
PlaceboDRUG
Sponsors & collaborators
Douglas Mental Health University Institutelead sponsor
Weston Family Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07213349 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.